Диссертация (1144820), страница 64
Текст из файла (страница 64)
– P. 91–92.392.Volkova M.V., Vasina V.I., Fomicheva E.V., Schwartz E.I. Comparativeanalysis of apo(a) gene alleles: distribution of pentanucleotide repeats in position 1373 and C/T transition in position +93 among patients with myocardial infarctionand a control group in St. Petersburg, Russia // Biochem.
Mol. Med. – 1997. – V.61(2). – P. 208–213.393.von Dadelszen P., Magee L.A. Pre-eclampsia: an update // Curr.Hypertens. Rep. – 2014. – V. 16(8). – P. 454.394.Walley A.J., Blakemore A.I., Froguel P. Genetics of obesity and theprediction of risk for health // Hum. Mol. Genet. – 2006. – V. 15, № 2. – P. R124–R130.395.Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation ofgenetic variants from high-throughput sequencing data // Nucleic Acids Research.– 2010. V. 38, № 16. – P. e164.396.Wang T., Huang Y., Xiao X.H., Wang D.M., Diao C.M., Zhang F., XuL.L., Zhang Y.B., Li W.H., Zhang L.L., Zhang Y., Sun X.F., Zhang Q.
Theassociation between common genetic variation in the FTO gene and metabolicsyndrome in Han Chinese // Chin. Med. J. (Engl). – 2010. – V. 123, № 14. – P.1852–1858.397.Wang W., Feng L., Zhang H., Hachy S., Satohisa S., Laurent L.C., ParastM., Zheng J., Chen D.B. Preeclampsia up-regulates angiogenesis-associated410411microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 inhuman placenta // J. Clin. Endocrinol.
Metab. – 2012. – V. 97. – P. E1051–1059.398.Wang X., Prins B.P., Sõber S., Laan M., Snieder H. Beyond genome-wideassociation studies: new strategies for identifying genetic determinants ofhypertension // Curr. Hypertens. Rep. – 2011. – V. 13 № 6. – P. 442–51.399.Wang X.M., Wu H.Y., Qiu X.J. Methylenetetrahydrofolate Reductase(MTHFR) Gene C677T Polymorphism and Risk of Preeclampsia: An UpdatedMeta-analysis Based on 51 Studies // Arch. Med.
Res. – 2013. – V. 44(3). – P.159–168.400.Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool fortranscriptomics // Nat. Rev. Genet. – 2009. – V. 10, № 1. – P. 57–63.401.Weedon-Fekjær M.S.,Sheng Y.,Sugulle M., Johnsen G.M., Herse F.,Redman C.W.,Lyle R.,Dechend R.,Staff A.C. Placental miR-1301 is dysregulatedin early-onset preeclampsia and inversely correlated with maternal circulatingleptin // Placenta. – 2014.
– V. 35(9). – P. 709-717.402.Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second geneticpolymorphism in methylenetetrahydrofolate reductase (MTHFR) associated withdecreased enzyme activity // Mol. Genet. Metab. – 1998. – V. 64(3). – P. 169-172.403.Wendland E.M., Duncan B.B., Belizán J.M., Vigo A., Schmidt M.I.Gestational diabetes and pre-eclampsia: common antecedents? // Arq.
Bras.Endocrinol. Metabol. – 2008. – V. 52, № 6. – P. 975–984.404.Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M.,Berndt S.I., Elliott A.L., Jackson A.U., Lamina C., Lettre G., Lim N., Lyon H.N.,McCarroll S.A., Papadakis K., Qi L., Randall J.C., Roccasecca R.M., Sanna S.,Scheet P., Weedon M.N., Wheeler E., Zhao J.H., Jacobs L.C., Prokopenko I.,Soranzo N., Tanaka T., Timpson N.J., Almgren P., Bennett A., Bergman R.N.,Bingham S.A., Bonnycastle L.L., Brown M., Burtt N.P., Chines P., Coin L.,Collins F.S., Connell J.M., Cooper C., Smith G.D., Dennison E.M., Deodhar P.,Elliott P., Erdos M.R., Estrada K., Evans D.M., Gianniny L., Gieger C., GillsonC.J., Guiducci C., Hackett R., Hadley D., Hall A.S., Havulinna A.S., Hebebrand J.,411412Hofman A., Isomaa B., Jacobs K.B., Johnson T., Jousilahti P., Jovanovic Z., KhawK.T., Kraft P., Kuokkanen M., Kuusisto J., Laitinen J., Lakatta E.G., Luan J.,Luben R.N., Mangino M., McArdle W.L., Meitinger T., Mulas A., Munroe P.B.,Narisu N., Ness A.R., Northstone K., O'Rahilly S., Purmann C., Rees M.G.,Ridderstråle M., Ring S.M., Rivadeneira F., Ruokonen A., Sandhu M.S., SaramiesJ., Scott L.J., Scuteri A., Silander K., Sims M.A., Song K., Stephens J., Stevens S.,Stringham H.M., Tung Y.C., Valle T.T., Van Duijn C.M., Vimaleswaran K.S.,Vollenweider P., Waeber G., Wallace C., Watanabe R.M., Waterworth D.M.,Watkins N.; Wellcome Trust Case Control Consortium, Witteman J.C., Zeggini E.,Zhai G., Zillikens M.C., Altshuler D., Caulfield M.J., Chanock S.J., Farooqi I.S.,Ferrucci L., Guralnik J.M., Hattersley A.T., Hu F.B., Jarvelin M.R., Laakso M.,Mooser V., Ong K.K., Ouwehand W.H., Salomaa V., Samani N.J., Spector T.D.,Tuomi T., Tuomilehto J., Uda M., Uitterlinden A.G., Wareham N.J., Deloukas P.,Frayling T.M., Groop L.C., Hayes R.B., Hunter D.J., Mohlke K.L., Peltonen L.,Schlessinger D., Strachan D.P., Wichmann H.E., McCarthy M.I., Boehnke M.,BarrosoI.,AbecasisG.R.,HirschhornJ.N.;Genetic InvestigationofANthropometric Traits Consortium.
Six new loci associated with body mass indexhighlight a neuronal influence on body weight regulation // Nat. Genet. – 2008. –V. 41, № 1. – P. 25–34.405.Williams A.G., Dhamrait S.S., Wootton P.T., Day S.H., Hawe E., PayneJ.R., Myerson S.G., World M., Budgett R., Humphries S.E., Montgomery H.E.Bradykinin receptor gene variant and human physical performance // J. Appl.Physiol. – 2004. – V.
96(3). – P. 938–942.406.Williams J.S., Hopkins P.N., Jeunemaitre X., Brown N.J. CYP4A11T8590C polymorphism, salt-sensitive hypertension, and renal blood flow // J.Hypertens. – 2011. – V. 29. – P. 1913–1918.407.Williams P.J., Pipkin F.B. The genetics of pre-eclampsia and otherhypertensive disorders of pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. –2011. – V. 25, № 4. – P. 405–417.412413408.Winham S.J., Motsinger-Reif A.A. The effect of retrospective sampling onestimates of prediction error for multifactor dimensionality reduction // Ann. Hum.Genet.
– 2011. – V. 75, № 1. – P. 46–61.409.Wu J., Liu Z., Meng K., Zhang L., Association of adiponectin gene(ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis //PLoS One. – 2014. – V. 9, № 4. – P. e95270.410.Wu L., Xi B., Zhang M., Shen Y., Zhao X., Wang T., Cheng H., Hou D.,Liu G., Wang X., Mi J. A sex-specific effect of the CYP17A1 SNP rs11191548 onblood pressure in Chinese children // J. Hum. Hypertens. – 2012. – V. 26(12). – P.731–736.411.Wu C., Li S., Cui Y. Genetic association studies: an information contentperspective. // Curr Genomics. – 2012.
– V. 13, № 7. – P. 566–73.412.XiaX.P.,ChangW.W.,CaoY.X.Meta-analysisofthemethylenetetrahydrofolate reductase C677T polymorphism and susceptibility topre-eclampsia // Hypertens. Res. –2012. – V. 35, № 12. – P. 1129–1134.413.Xiang Y., Zhang X., Li Q., Xu J., Zhou X., Wang T., Xing Q., Liu Y.,Wang L., He L., Zhao X. Promoter hypomethylation of TIMP3 is associated withpre-eclampsia in a Chinese population // Mol.
Hum. Reprod. - 2013. – V. 19(3). –P. 153-159.414.Xu P., Zhao Y., Liu M., Wang Y., Wang H., Li Y.X., Zhu X., Yao Y.,Wang H., Qiao J., Ji L., Wang Y.L. Variations of microRNAs in human placentasand plasma from preeclamptic pregnancy. // Hypertension. – 2014. – V. 63. – P.1276–1284.415.Xu S., Hu Z., Generalized Linear Model for Interval Mapping ofQuantitative Trait Loci // Theor. Appl. Genet.
– 2010. – V. 121, №1. – P. 47–63.416.Yang J., Shang J., Zhang S., Li H. Liu H.The role of the renin–angiotensin–aldosterone system in preeclampsia: genetic polymorphisms andmicroRNA // Journal of Molecular Endocrinology. – 2013. – V. 50. – P. R53–R66.417.Yang Q., Lu J., Wang S., Li H., Ge Q., Lu Z. Application of next-generation sequencing technology to profile the circulating microRNAs in the413414serum ofpreeclampsia versus normal pregnant women // Clin. Chim. Acta.
–2011. – V. 20;412(23-24). P. 2167-2173.418.Yi N., Banerjee S. Hierarchical generalized linear models for multiplequantitative trait locus mapping // Genetics. – 2009. – V. 181, № 3. – P. 1101–1113.419.Yi N., Kaklamani V.G., Pasche B. Bayesian analysis of geneticinteractions in case-control studies, with application to adiponectin genes andcolorectal cancer risk // Ann.
Hum. Genet. – 2011. – V. 75, № 1. – P. 90–104.420.Young B.C., Levine R.J., Karumanchi S.A. Pathogenesis of preeclampsia// Annu. Rev. Pathol. – 2010. – V. 5. – P. 173–92.421.Yu H., Zhang Y., Liu G. Relationship between polymorphism of theangiotensin-converting enzyme gene and the response to angiotensin-convertingenzyme inhibition in hypertensive patients // Hypertens.
Res. – 2003. – V. 26(11).– P. 881–886.422.Yu L., Chen M., Zhao D., Yi P., Lu L., Han J., Zheng X., Zhou Y., Li L.The H19 gene imprinting in normal pregnancy and pre-eclampsia // Placenta. –2009. – V. 30. – P. 443–447.423.Yuen R.K., Penaherrera M.S., von Dadelszen P., McFadden D.E.,Robinson W.P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
